Revolutionizing blood collection isn’t just a technical breakthrough — it’s a lifeline for millions navigating cancer care. Rachelle Turiello, CEO, and Renna Nouwairi, COO of Avant Genomics, share how they are building a technology that improves DNA preparation, strengthens the accuracy of liquid biopsy testing, and makes early detection and treatment monitoring more accessible for patients. From their unexpected partnership in the lab to co-founding a biotech startup during pregnancy, their story blends hard science with human empathy, resilience, and purpose. This conversation uncovers the courage it takes to disrupt healthcare, the discipline required to listen to patients and partners, and the vision driving two women to transform what personalized medicine can mean for families worldwide.Love the show? Subscribe, rate, review, and share! Visit katebyrne.co